Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
In all, participants who received tirzepatide Eli Lillys (NYSE:LLY) tirzepatide achieved up to 15.7% weight loss in the SURMOUNT-2 study, sparking a potential tirzepatide versus semaglutide competition in the obesity and type 2 diabetes treatment markets
However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons
Morning nausea common
Treatment logistics are simple: an intramuscular injection into the upper arm or glute, typically weekly, from a licensed provider, with mild possible injection-site effects and ongoing clinical oversight
Patients should be advised about the urine discoloration (to avoid alarm) and counseled to report any persistent side effects
.png)
